NYSE:NNVC

Nanoviricides Stock Insider Trading

Healthcare > Biotechnology

Buy NNVC

*Your capital is at risk

$1.32

-0.0800 (-5.71%)

At Close: Jun 22, 2026

NanoViricides Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 18.35M and sold 1.63M NNVC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	18.35M shares
● Sell	1.63M shares
90% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Aug 08, 2022 Sell	Common Stock, par value $0.001 per share G-Gift	Diwan Anil President	CEO / President	94 471 Value: $0
Aug 08, 2022 Sell	Common Stock, par value $0.001 per share G-Gift	Diwan Anil President	CEO / President	94 471 Value: $0
Feb 07, 2020 Buy	Common Stock J-Other	Jawadakar Makarand	Director	0 Value: $0
Feb 07, 2020 Buy	Common Stock J-Other	Jawadakar Makarand	Director	0 Value: $0
Jun 02, 2019 Buy	Common Stock J-Other	Day Mark D.	Director	0 Value: $0
Jun 02, 2019 Buy	Common Stock J-Other	Day Mark D.	Director	0 Value: $0
May 21, 2018 Buy	Common Stock, par value $0.001 per share M-Exempt	Boniuk Milton 10 Percent Owner	10% Owner	5 500 000 Value: $5.50M
May 21, 2018 Buy	Series A Conv Pref Stock, par value $0.001 per share A-Award	Boniuk Milton 10 Percent Owner	10% Owner	150 000 Value: $0
May 21, 2018 Buy	10% Coupon Series C Convertible Debenture M-Exempt	Boniuk Milton 10 Percent Owner	10% Owner	0 Value: $0
May 21, 2018 Buy	Series A Conv Pref Stock, par value $0.001 per share A-Award	Boniuk Milton 10 Percent Owner	10% Owner	150 000 Value: $0
May 21, 2018 Buy	10% Coupon Series C Convertible Debenture M-Exempt	Boniuk Milton 10 Percent Owner	10% Owner	0 Value: $0
May 21, 2018 Buy	Common Stock, par value $0.001 per share M-Exempt	Boniuk Milton 10 Percent Owner	10% Owner	5 500 000 Value: $5.50M
May 01, 2018 Buy	Common Stock J-Other	Seymour Eugene Insider	Other	0 Value: $0
May 01, 2018 Buy	Common Stock J-Other	Seymour Eugene Insider	Other	0 Value: $0
Jul 11, 2017 Buy	Common Stock, par value $0.001 per share A-Award	Boniuk Milton 10 Percent Owner	10% Owner	120 744 Value: $166.6K
Jul 11, 2017 Buy	Common Stock, par value $0.001 per share A-Award	Boniuk Milton 10 Percent Owner	10% Owner	120 744 Value: $166.6K
May 04, 2017 Buy	Common Stock, par value $0.001 per share A-Award	Boniuk Milton 10 Percent Owner	10% Owner	149 478 Value: $165.9K
May 04, 2017 Buy	Common Stock, par value $0.001 per share A-Award	Boniuk Milton 10 Percent Owner	10% Owner	149 478 Value: $165.9K
Feb 21, 2017 Buy	Common Stock J-Other	Boniuk Milton Insider	Other	0 Value: $0
Feb 21, 2017 Buy	Common Stock J-Other	Boniuk Milton Insider	Other	0 Value: $0
Feb 21, 2017 Buy	Common Stock J-Other	Stephenson Fournier, Pllc Insider	Other	0 Value: $0
Feb 21, 2017 Buy	Common Stock J-Other	Stephenson Fournier, Pllc Insider	Other	0 Value: $0
Feb 21, 2017 Buy	Common Stock, par value $0.001 per share M-Exempt	Boniuk Milton 10 Percent Owner	10% Owner	1 746 288 Value: $2.01M
Feb 21, 2017 Buy	Common Stock, par value $0.001 per share A-Award	Boniuk Milton 10 Percent Owner	10% Owner	153 611 Value: $165.9K
Feb 21, 2017 Buy	8% Coupon Series B Convertible Debenture M-Exempt	Boniuk Milton 10 Percent Owner	10% Owner	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NANOVIRICIDES, INC

NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular...

Read Full Profile Here